Treanda and Breastfeeding
Although no adequate research has been done on using Treanda (bendamustine) while breastfeeding, it is thought that this drug would likely pass through breast milk to some extent. Because potentially serious side effects are associated with this drug, the manufacturer recommends that women avoid breastfeeding while undergoing this particular chemotherapy treatment.
Treanda® (bendamustine) is a prescription medication used to treat certain types of leukemia and lymphoma. It is unknown whether this drug passes through breast milk. The manufacturer recommends that women either stop breastfeeding or not use Treanda.
There is very little information available about Treanda and breastfeeding. No research has been done to see if Treanda passes through breast milk, or if it would harm a nursing child. While this lack of information is frustrating, it is important to keep in mind that studies of medications are rarely done in breastfeeding women, as this would usually expose an infant, who will not directly benefit from the medication, to possible risks.
Based on the properties of Treanda, it is expected to pass through breast milk to some extent. Like other cancer medications, Treanda is associated with potentially serious side effects. Because the potential for these problems in a nursing infant cannot be ruled out, women receiving this drug are generally advised to avoid breastfeeding.
You should discuss breastfeeding and Treanda use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.